Brian McClenic, MD
Interventional Pain Medicine · Munster, INNPI 1801845078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 86.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $944 and has fallen 58.3% since, to $394 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.
Across 81 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$142
- Boston Scientific$82
- Stryker$64
- Novartis$49
- Relievant Medsystems, Inc.$22
- plus $21 from 1 others
What the payments were for
- Travel & lodging$1616%
- Food & beverage$2,60294%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 67 | $2,383 |
| Medtronic(2 entities) | 6 | $142 |
| Boston Scientific | 3 | $82 |
| Stryker | 2 | $64 |
| Novartis | 1 | $49 |
| Relievant Medsystems, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$799
- Proclaim Family of SCS IPGs$145
- ETERNA$143
- Proclaim IPG$129
How this compares
$2,762 in reported general payments places this provider in the 35th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 238 | $4,178 |
| Gabapentin | 182 | $2,945 |
| Pregabalin | 97 | $2,633 |
| Diclofenac Sodium | 17 | $1,546 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 80 | $1,507 |
| Fentanyl | 12 | $946 |
| Tramadol Hcl | 134 | $647 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $397 |
| Tizanidine Hcl | 29 | $292 |
| Cyclobenzaprine Hcl | 19 | $222 |
| Duloxetine Hcl | 14 | $194 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $150 |
| Amitriptyline Hcl | 11 | $94 |
| Cephalexin | 11 | $66 |
| Methylprednisolone | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Munster
- Nikhil ShettyMunster$29K
- Shariq IbrahimMunster$10K
- Shanu KondamuriMunster$8K
- Prasanth NuthakkiMunster$7K
- Brett BonyngeMunster$6K
- Satish DasariMunster$5K
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.